top of page
Market Access Transformation (MAT) specializes in developing agile technology platforms that enable healthcare manufacturers to gather insights and assess the commercial viability of their products.
See first hand how we provide the most robust and timely insights to our biopharmaceutical and healthcare clients around the world through both Rapid Payer Response™ (RPR) and Envision™.
Rapid Payer Response (RPR) is an agile, on-demand platform that allows you to conduct the most robust, insightful, research via direct payer engagement.
Envision™ is the only sydicated research platform that provides forward thinking evaluations of the market access viability for a product after it has received positive EMA or FDA guidance.